Glen C. MacDonald - Feb 18, 2022 Form 4 Insider Report for Sesen Bio, Inc. (CARM)

Signature
/s/ Mark R. Sullivan, attorney-in-fact
Stock symbol
CARM
Transactions as of
Feb 18, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 07:33 PM
Next filing
Feb 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARM Common Stock Award $0 +309K $0.00 309K Feb 18, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") which shall vest annually in equal amounts over a four-year period following the grant date, so long as the reporting person remains employed by Sesen Bio, Inc. (the "Company"). Each RSU represents a contingent right to receive one share of the Company's common stock. The compensation committee of the Company approved the grant to the reporting person, based on market analysis by Radford of public, pre-commercial and commercial biopharmaceutical companies.